Special Coagulation Labs
Explore Our Products
ATS-13® Activity Assay
What is your testing algorithm for patients suspected of having thrombotic thrombocytopenic purpura (TTP)?
Factor VIII Antibody Screen
Quickly detect Factor VIII inhibitors in your Hemophilia A population.
PF4 Enhanced® and PF4 IgG Assay
Detect harmful antibodies that cause Heparin Induced Thrombocytopenia (HIT).
Upcoming Events,
Webinars & Workshops
Keep Up With Us
News & Blogs
Werfen Completes Acquisition of Immucor, Inc.
WERFEN COMPLETES ACQUISITION OF IMMUCOR, INC., EXPANDING LEADERSHIP IN SPECIALIZED DIAGNOSTICS Werfen announced in November 2022 that it reached an agreement to acquire Immucor, Inc. for approximately US$2 billion. The transaction has received all necessary regulatory approvals. The Transfusion and...
News & Blogs
EFI 2023 - Bienvenue à Nantes, France!
Immucor is excited to see you at EFI 2023 - Bienvenue à Nantes, France! As...
News & Blogs
Corporate Social Responsibility
Immucor is dedicated to supporting our global and local communities and environments through the giving...
News & Blogs
PRESS RELEASE: Immucor and Pirche Announce Multi-Year Partnership
NORCROSS, Ga. and BERLIN, DE Oct. 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global...
News & Blogs
CYBERSECURITY is never a destination. It is a journey we are on together.
At Immucor, we are dedicated to protecting our products and the data they contain against...
